These results might indicate that potential therapeutic effects of MFE for diabetic dementia are associated with neuronal cell protection through regulating Alzheimer's disease-associated pathogens and activation of the p-CREB/BDNF pathway. This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.